Annotation Detail

Information
Associated Genes
GSTO2
Associated Variants
GSTO2 p.Asn142Asp (p.N142D) ( ENST00000450629.6, ENST00000338595.7, ENST00000369707.2 )
GSTZ1 p.Glu33Lys (p.E33K) ( ENST00000556627.5, ENST00000557639.5, ENST00000553586.5, ENST00000554279.5, ENST00000216465.10, ENST00000361389.8, ENST00000349555.7, ENST00000393734.5, ENST00000557053.5 )
GSTZ1 p.Glu33Gln (p.E33Q) ( ENST00000216465.10, ENST00000557639.5, ENST00000553586.5, ENST00000554279.5, ENST00000556627.5, ENST00000557053.5, ENST00000361389.8, ENST00000393734.5, ENST00000349555.7 )
GSTZ1 p.Glu33Ter (p.E33*) ( ENST00000216465.10, ENST00000554279.5, ENST00000553586.5, ENST00000557639.5, ENST00000556627.5, ENST00000557053.5, ENST00000393734.5, ENST00000349555.7, ENST00000361389.8 )
GSTO2 p.Asn142Asp (p.N142D) ( ENST00000338595.7, ENST00000369707.2, ENST00000450629.6 )
GSTZ1 p.Glu33Lys (p.E33K) ( ENST00000216465.10, ENST00000349555.7, ENST00000361389.8, ENST00000393734.5, ENST00000553586.5, ENST00000554279.5, ENST00000556627.5, ENST00000557053.5, ENST00000557639.5 )
GSTZ1 p.Glu33Gln (p.E33Q) ( ENST00000216465.10, ENST00000349555.7, ENST00000361389.8, ENST00000393734.5, ENST00000553586.5, ENST00000554279.5, ENST00000556627.5, ENST00000557053.5, ENST00000557639.5 )
GSTZ1 p.Glu33Ter (p.E33*) ( ENST00000216465.10, ENST00000349555.7, ENST00000361389.8, ENST00000393734.5, ENST00000553586.5, ENST00000554279.5, ENST00000556627.5, ENST00000557053.5, ENST00000557639.5 )
Associated Disease
Carcinoma of bladder
Source Database
DisGeNET
Description
Bladder cancer risk overall was associated with GSTO2 Asn142Asp (homozygous; OR=1.4; 95% CI: 1.0-1.9; P for trend=0.06) and GSTZ1 Glu32Lys (homozygous; OR=1.3; 95% CI: 0.9-1.8; P for trend=0.06).
Pubmed
22306368
Original source reporting the Gene Disease association
BeFree
DisGENET score for the Gene Disease association
0.00081432561624091
Year of publication
2012
Drugs